The Australia and New Zealand Fetal Bovine Serum market was valued at $20 million in 2020 and is projected to reach $35 million by 2030, registering a CAGR of 5.2% from 2021 to 2030.
Fetal bovine serum (FBS) is considered as an ideal medium growth supplement and is usually preferred over other types of sera available such as Horse Sea, goat sera, and others. High levels of nutrients and optimal combination of growth factors make it a suitable growth supplement for cell cultures. Further, the significantly lower content of antibodies compared to adult and newborn sera minimizes the risk of antibody cross reaction with cells in culture. FBS finds its application on several research purposes including cancer research, development of biopharmaceuticals, and other research purposes. In addition, sera are widely used as an additional growth supplement along with the culture media preparation made precisely for the growth, storage, maintenance, and transport of microorganisms and different types of cells. The array of various media available in research allows the culturing of cell types and microorganisms. The quality of FBS is determined chiefly at the blood collection site and the raw serum processing center. Appropriate collection is fundamental to maintaining the natural growth-promoting properties of fetal blood, thus achieving consistent and superior performance of the final Fetal Bovine Serum products.
Rise in research and development regarding the development of biopharmaceuticals fuel the growth of the fetal bovine serum industry. In addition, the constant expansion of biopharmaceutical research is anticipated to surge the demand of the production and supply chain for FBS market in near future. Moreover, increase in investments and funding for research interventions in both developed and developing countries drives the market growth. However, animal welfare and ethical & scientific concerns associated with the use of fetal bovine restrict the fetal bovine serum market growth. However, untapped potential of the emerging markets is anticipated to provide lucrative opportunities to the key players involved in the fetal bovine serum market.
By application, the market is categorized into biopharmaceuticals, cell culture media, human and animal vaccine production, and others. The cell culture segment was the highest contributor to the market in 2020 and is anticipated to maintain its dominance throughout the forecast period.
Other major factors that drive the overall FBS market in Australia and New Zealand include increased funding by the government agencies and rise in focus to develop biopharmaceuticals
The report provides a comprehensive analysis of the leading companies operating in the Australia and New Zealand market such as Atlas Biologicals, Biological Industries, Bio Techne, Biowest, GE Healthcare, HiMedia Laboratories Pvt. Ltd., Merck KGaA (Sigma Aldrich, Pan Biotech, Rocky Mountain Biologicals, and Thermo Fisher Scientific Inc. The other players in the value chain (not included in the report) include Takara Bio, Inc., Tissue Culture Biologicals, Caisson Laboratories, Inc., Cell Culture Technologies LLC and Biomol GmbH and Nucleus Biologics.
Rise in research and development regarding the development of biopharmaceuticals fuel the growth of the fetal bovine serum industry. In addition, the constant expansion of biopharmaceutical research is anticipated to surge the demand of the production and supply chain for FBS market in near future. Moreover, increase in investments and funding for research interventions in both developed and developing countries drives the market growth. However, animal welfare and ethical & scientific concerns associated with the use of fetal bovine restrict the fetal bovine serum market growth. However, untapped potential of the emerging markets is anticipated to provide lucrative opportunities to the key players involved in the fetal bovine serum market.
By application, the market is categorized into biopharmaceuticals, cell culture media, human and animal vaccine production, and others. The cell culture segment was the highest contributor to the market in 2020 and is anticipated to maintain its dominance throughout the forecast period.
Other major factors that drive the overall FBS market in Australia and New Zealand include increased funding by the government agencies and rise in focus to develop biopharmaceuticals
The report provides a comprehensive analysis of the leading companies operating in the Australia and New Zealand market such as Atlas Biologicals, Biological Industries, Bio Techne, Biowest, GE Healthcare, HiMedia Laboratories Pvt. Ltd., Merck KGaA (Sigma Aldrich, Pan Biotech, Rocky Mountain Biologicals, and Thermo Fisher Scientific Inc. The other players in the value chain (not included in the report) include Takara Bio, Inc., Tissue Culture Biologicals, Caisson Laboratories, Inc., Cell Culture Technologies LLC and Biomol GmbH and Nucleus Biologics.
KEY BENEFITS FOR STAKEHOLDERS
- The study provides an in-depth analysis of the Australia and New Zealand fetal bovine serum market along with the current trends and future estimations to elucidate the imminent investment pockets.
- A comprehensive analysis of the factors that drive and restrict the market growth is provided in the report.
- Comprehensive quantitative analysis of the industry from 2020 to 2030 is provided to enable the stakeholders to capitalize on the prevailing market opportunities.
- Extensive analysis of the key segments of the industry helps to understand the products and end users of Australia and New Zealand fetal bovine serum used across the globe.
- Key market players and their strategies have been analysed to understand the competitive outlook of the market.
KEY MARKET SEGMENTS
By Origin
- Australia Origin
- New Zealand Origin
- US Origin
- Mexico Origin
- Brazil Origin
By Application
- Biopharmaceuticals
- Cell Culture
- Human & Animal Vaccine Production
- Others
By End User
- Biotechnology & Pharmaceutical Industry
- Academic Institute
- Research Laboratory
KEY MARKET PLAYERS
- Atlas Biologicals
- Biological Industries
- Bio Techne
- Biowest
- GE Healthcare
- HiMedia Laboratories Pvt. Ltd.
- Merck KGaA (Sigma Aldrich)
- Pan Biotech
- Rocky Mountain Biologicals
- Thermo Fisher Scientific Inc.
Please note:
- Online Access price format is valid for 60 days access. Printing is not enabled.
- PDF Single and Enterprise price formats enable printing.
Table of Contents
CHAPTER 1: INTRODUCTION
CHAPTER 2: EXECUTIVE SUMMARY
CHAPTER 3: MARKET LANDSCAPE
CHAPTER 4: AUSTRALIA AND NEW ZEALAND FETAL BOVINE SERUM MARKET BY ORIGIN
CHAPTER 5: AUSTRALIA AND NEW ZEALAND FETAL BOVINE SERUM MARKET BY APPLICATION
CHAPTER 6: AUSTRALIA AND NEW ZEALAND FETAL BOVINE SERUM MARKET BY END USER
CHAPTER 7: COMPANY PROFILES
List of Tables
List of Figures
Methodology
The analyst offers exhaustive research and analysis based on a wide variety of factual inputs, which largely include interviews with industry participants, reliable statistics, and regional intelligence. The in-house industry experts play an instrumental role in designing analytic tools and models, tailored to the requirements of a particular industry segment. The primary research efforts include reaching out participants through mail, tele-conversations, referrals, professional networks, and face-to-face interactions.
They are also in professional corporate relations with various companies that allow them greater flexibility for reaching out to industry participants and commentators for interviews and discussions.
They also refer to a broad array of industry sources for their secondary research, which typically include; however, not limited to:
- Company SEC filings, annual reports, company websites, broker & financial reports, and investor presentations for competitive scenario and shape of the industry
- Scientific and technical writings for product information and related preemptions
- Regional government and statistical databases for macro analysis
- Authentic news articles and other related releases for market evaluation
- Internal and external proprietary databases, key market indicators, and relevant press releases for market estimates and forecast
Furthermore, the accuracy of the data will be analyzed and validated by conducting additional primaries with various industry experts and KOLs. They also provide robust post-sales support to clients.
LOADING...
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 80 |
| Published | September 2021 |
| Forecast Period | 2020 - 2030 |
| Estimated Market Value ( USD | $ 20 million |
| Forecasted Market Value ( USD | $ 35 million |
| Compound Annual Growth Rate | 5.8% |
| Regions Covered | Australia, New Zealand |
